Tirzepatide is a glucagon-like peptide 1 agonist that induces weight loss by controlling appetite.
The medication has a dual-action design, mimicking the action of not one but two unique incretin hormones involved in blood sugar control: on-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP).
Losing excess weight can provide many health benefits by improving cardiovascular health, metabolic health, and restoring hormones, such as testosterone, to their baseline levels.